Celltrion, Inc. Stock OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 40,866B 26.67B 23.36B 21.51B 19.97B 37.92B 2,544B 38.43B 258B 100B 1,249B 100B 97.95B 4,329B | P/E 2026 * |
27.6x | P/E 2027 * | 24.4x |
|---|---|---|---|---|---|
| Enterprise Value | 43.05B 28.09M 24.6M 22.66M 21.03M 39.94M 2.68B 40.48M 271M 106M 1.32B 105M 103M 4.56B | EV / Sales 2026 * |
7.94x | EV / Sales 2027 * | 6.84x |
| Free-Float |
58.37% | Yield 2026 * |
0.41% | Yield 2027 * | 0.45% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 26.32B | |
| -0.07% | +6.30% | +3.98% | +10.51% | 50.25B | |
| -0.99% | +0.40% | +412.76% | +612.50% | 40.39B | |
| +0.76% | +7.16% | +27.46% | -4.50% | 34.38B | |
| -1.06% | +7.42% | +27.02% | +61.49% | 34.4B | |
| +0.74% | +0.72% | - | - | 16.64B | |
| -2.57% | +3.48% | +71.84% | +132.67% | 16.14B | |
| +1.25% | +1.28% | +15.20% | +22.38% | 13.71B | |
| +1.96% | +5.94% | +101.05% | +101.05% | 13.75B | |
| -3.88% | +7.71% | +1,729.41% | +682.39% | 12.69B | |
| Average | -0.37% | +9.48% | +298.59% | +202.31% | 25.82B | |
| Weighted average by Cap. | -0.32% | +7.09% | +201.40% | +184.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,425B 3.54B 3.1B 2.86B 2.65B 5.03B 338B 5.1B 34.18B 13.3B 166B 13.29B 13B 575B | 6,180B 4.03B 3.53B 3.25B 3.02B 5.73B 385B 5.81B 38.94B 15.15B 189B 15.14B 14.81B 655B |
| Net income | 1,518B 990M 867M 799M 742M 1.41B 94.47B 1.43B 9.56B 3.72B 46.37B 3.72B 3.64B 161B | 1,698B 1.11B 971M 894M 830M 1.58B 106B 1.6B 10.7B 4.16B 51.89B 4.16B 4.07B 180B |
| Net Debt | 2,182B 1.42B 1.25B 1.15B 1.07B 2.02B 136B 2.05B 13.75B 5.35B 66.66B 5.35B 5.23B 231B | 1,428B 932M 816M 752M 698M 1.32B 88.88B 1.34B 9B 3.5B 43.63B 3.5B 3.42B 151B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
